»¯ÁƳ£¼ûµÄ²»Á¼·´Ó¦ÓÐÄÄЩ£¿ÈçºÎÔ¤·À£¿¡¡¡¡¡¡
£¨1£©³£¼û²»Á¼·´Ó¦£ºÏû»¯µÀ·´Ó¦¡¢ÍÑ·¢¡¢¹ÇËèÒÖÖÆ¡£¡¡¡¡¡¡
1£©¸ßÄòËá¡¢¸ß¼ØѪ֢£º¶àÖÖÒ©Îï¡¢³õÖβ¡Àý¡£±ðàÑ´¼¡¢Ë®»¯ºÍ¼î»¯ÄòÒº¡¢ÀûÄò¡£¡¡¡¡¡¡
2£©¹ýÃô£ºL-Asp(5%¡«20%)¡¢²©À´/ƽÑôùËØ¡¢VP-16¡¢VM-26¡¢MTX¡¢¿¨²¬¡¢ÃÀÂÞ»ª¡¢½¡Ôñ£¨25%£©¡£¡¡¡¡¡¡
3£©Ò©ÎïÈÈ£ºHHT¡¢AraC¡¢BLM£¨30%£©¡¢Æ½ÑôùËØ¡¢Ë³²¬¡¢VP-16¡¢ÃÀÂÞ»ª¡£¡¡¡¡¡¡
4£©ð¤Ä¤Ñ×£ºMTX¡¢AraC¡¢AMSA¡¢¿¨ÄªË¾Í¡¡¢DNR¡¢AMDµÈ¡¡¡¡¡¡
5£©¾Ö²¿´Ì¼¤¡¢¾²ÂöÑ×£ºµª½æÀà¡¢VCR/VDS¡¢Ýì»·Àà¡¢ATG¡¢VP-16¡¢VM-26¡£0.5%¡«1.0% Procarine·â±Õ¡¢MgSO4ʪ·ó¡¢¾²ÂöÑ×Èí¸à¡¢×ÏÉ«ÏûÖ׸ࡣ¡¡¡¡¡¡
6£©µÍѪѹ£ºVCR¡¢VP-16¡¢ÃÀÂÞ»ª¡¢¼×»ùÜÐë¡¢½¡Ôñ¡£¡¡¡¡¡¡
7£©³öѪÐÔ°òë×Ñ×£ºCTX¡¢Òì»·Á×õ£°·¡¢L-AsP¡£Ë®»¯¡¢¼î»¯ÄòÒº¡¢Mesna(CTXºÍÒ컷ʱ)¡£¡¡¡¡¡¡
8£©¸Î¶¾ÐÔ£ºMTX¡¢CTX¡¢DNR¡¢AraC¡¢L-AsP¡¢VP-16¡¢µª½æ¡¢BCNU¡¢ATRA¡¢¶þÑõ»¯¶þÉé¡¢BLM¡¢Ë³²¬/¿¨²¬¡¢AMSA¡¢½¡Ôñ£¨Gemcitabine£©µÈ¡£±£¸ÎÖÎÁÆ£¨¹Èë׸Êëĵȣ©¡£¡¡¡¡¡¡
9£©Ðļ¡¶¾ÐÔ£ºÝì»·ÀࣨDNR¡¢ADM¡¢MTZµÈ£©¡¢HHT¡¢¶þÑõ»¯¶þÉé¡¢AMSA¡¢VDS/VCR¡¢BLM¡¢Òì»·Á×õ£°·¡¢½¡Ôñ¡£¿ÉÓèÃŶ¬°±Ëá¼Øþ¡£¡¡¡¡¡¡
10£©Éö¶¾ÐÔ£ºÒì»·Á×õ£°·¡¢MTX¡¢ßÁà«°¢Ã¹ËØ¡¢Ë³²¬/¿¨²¬¡¢L-AsP¡¢VP-16¡¢VDS¡¢DNR¡¢¿¨ÄªË¾Í¡¡¢¶þÑõ»¯¶þÉé¡£ÉöС¹Ü¶¾ÐÔ£ºË³²¬¡£¡¡¡¡¡¡
11£©Éñ¾¶¾ÐÔ£ºVCR/VDS¡¢AraC¡¢L-AsP¡¢MTX¡¢ÍØÆËÌ濵¡¢CTXºÍÒì»·¡¢±½¶¡Ëᵪ½æ¡¢DITC¡¢ADM¡¢¼×»ùÜÐë¡¢µª½æ¡¢Ë³²¬/¿¨²¬¡¢VP-16¡¢ÃÀÂÞ»ª¡¢Fludarabin¡¢½¡Ôñ¡£¡¡¡¡¡¡
12£©¶ú¶¾ÐÔ£ºË³²¬/¿¨²¬¡£¡¡¡¡¡¡
13£©Æ¤·ôÉ«ËسÁ×Å£ºÆ½ÑôùËØ¡¢°×Ïû°²¡¢CTX